Search

Your search keyword '"Balzarotti, M."' showing total 305 results
Start Over Author "Balzarotti, M."
305 results on '"Balzarotti, M."'

1. Primary Mediastinal B‐cell Lymphoma, a nationwide real‐life retrospective study from Fondazione Italiana Linfomi (FIL)

Author

Iannitto, E., primary, Balzarotti, M., additional, Martelli, M., additional, Zinzani, P., additional, Tucci, A., additional, Di Rocco, A., additional, Cavallo, F., additional, Usai, S. V., additional, Guidetti, A., additional, Ravano, E., additional, Merli, F., additional, Botto, B., additional, Pelosini, M., additional, Tecchio, C., additional, Spina, M., additional, Derenzini, E., additional, Finotto, S., additional, Mola, B., additional, Pinto, A., additional, Zanni, E., additional, Battistini, R., additional, Hohaus, S., additional, Dogliotti, I., additional, Gini, G., additional, Zilioli, V. R., additional, De Lorenzo, S., additional, Dodero, A., additional, Broccoli, A., additional, Maggi, A., additional, Mannarella, C., additional, Chiarenza, A., additional, Pastore, D., additional, Cascavilla, N., additional, Musto, P., additional, Stelitano, C., additional, Di Raimondo, F., additional, Di Renzo, N., additional, Liberati, A. M., additional, Salerno, M., additional, Scalone, R., additional, Nassi, L., additional, Patti, C., additional, Polizzi, V., additional, Guarini, A., additional, Amato, G., additional, Ciccone, G., additional, Evangelista, A., additional, Lo Presti, F., additional, La Porta, A., additional, Mannina, D., additional, Calogero, R. D., additional, Musso, M., additional, and Consoli, U., additional

Published
2023
Full Text
View/download PDF

2. The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)

Author

Luminari, S., Biasoli, I., Versari, A., Rattotti, S., Bottelli, C., Rusconi, C., Merli, F., Spina, M., Ferreri, A.J.M., Zinzani, P.L., Gallamini, A., Franceschetto, A., Boccomini, C., Franceschetti, S., Salvi, F., Raimondo, F.D., Carella, A.M., Micol, Q., Balzarotti, M., Musto, P., and Federico, M.

Published
2014
Full Text
View/download PDF

3. S221: BORTEZOMIB TO R-DHAP COMPARED TO R-DHAP IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE TO STEM CELL TRANPLANTATION: FINAL RESULTS OF PHASE II RANDOMIZED FIL-VERAL12

Author

Chiappella, A., primary, Balzarotti, M., additional, Botto, B, additional, Castiglione, A., additional, Cavallo, F., additional, Usai, S. V., additional, Zanni, M., additional, Califano, C., additional, Re, F., additional, Ghiggi, C., additional, Olivieri, A., additional, Corradini, P., additional, Liberati, A. M., additional, Volpetti, S., additional, Michieli, M. G., additional, Tucci, A, additional, Gaidano, G., additional, Tani, M., additional, Ciambelli, F., additional, Musuraca, G., additional, Vallisa, D., additional, Merli, F., additional, Molinari, A. L., additional, Tafuri, A., additional, Zilioli, V. R., additional, Marino, D., additional, Stelitano, C., additional, Pileri, S. A., additional, Ciccone, G., additional, and Vitolo, U., additional

Published
2022
Full Text
View/download PDF

4. PB2132: COPANLISIB PLUS RITUXIMAB-BENDAMUSTINE FOR RELAPSED-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RECRUITMENT UPDATE ON AN ONGOING PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI (FIL_COPA-RB)

Author

Novo, M., primary, Castellino, A., additional, Chiappella, A., additional, Ciccone, G., additional, Balzarotti, M., additional, Arcari, A., additional, Scarpa, E., additional, Tucci, A., additional, Di Renzo, N., additional, Tarantini, G., additional, Gini, G., additional, Moretti, M., additional, Mannina, D., additional, Di Rocco, A., additional, Spina, M., additional, and Vitolo, U., additional

Published
2022
Full Text
View/download PDF

7. A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS WITH COMPLETE METABOLIC RESPONSE AFTER STANDARD IMMUNOCHEMOTHERAPY.

Author

Davies, A. J., Zucca, E., Ceriani, L., Kryachok, I., Ciccone, G., Botto, B., Balzarotti, M., Tucci, A., Rusconi, C., Usai, S. V., Pennese, E., Arcaini, L., Dabrowska‐Iwanicka, A., Ferreri, A. J. M., Merli, F., Zhao, W., Hodgson, D., Rigacci, L., Cellini, C., and Stelitano, C.

Subjects
LYMPHOMAS
Abstract

The IELSG37 (NCT01599559) randomized trial was planned with a non-inferiority design to test whether RT can be omitted in PMBCL patients who achieve a complete metabolic response (CMR) after immunochemotherapy. Mediastinal radiotherapy (RT) may consolidate responses to dose-intensive immunochemotherapy; however, it increases the risk of second malignancies and coronary or valvular heart disease. B Introduction: b Primary mediastinal B-cell lymphoma (PMBCL) has a poor prognosis if remission is not rapidly achieved, or the disease recurs. [Extracted from the article]

Published
2023
Full Text
View/download PDF

10. THE ELDERLY PROGNOSTIC INDEX (EPI) PREDICTS EARLY MORTALITY IN OLDER PATIENTS WITH DLBCL. A SUBSTUDY OF THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI (FIL)

Author

Merli, F., primary, Tucci, A., additional, Arcari, A., additional, Rigacci, L., additional, Cavallo, F., additional, Cabras, G., additional, Alvarez, I., additional, Fabbri, A., additional, Re, A., additional, Ferrero, S., additional, Puccini, B., additional, Usai, S. V., additional, Ferrari, A., additional, Cencini, E., additional, Pennese, E., additional, Zilioli, V. R., additional, Marino, D., additional, Balzarotti, M., additional, Cox, M. C., additional, Zanni, M., additional, Rocco, A., additional, Lleshi, A., additional, Botto, B., additional, Hohaus, S., additional, Merli, M., additional, Sartori, R., additional, Gini, G., additional, Nassi, L., additional, Musuraca, G., additional, Tani, M., additional, Bottelli, C., additional, Kovalchuk, S., additional, Re, F., additional, Flenghi, L., additional, Molinari, A., additional, Tarantini, G., additional, Chimienti, E., additional, Marcheselli, L., additional, Mammi, C., additional, Luminari, S., additional, and Spina, M., additional

Published
2021
Full Text
View/download PDF

11. IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL

Author

Martelli, M., primary, Zucca, E., additional, Botto, B., additional, Kryachok, I., additional, Ceriani, L., additional, Balzarotti, M., additional, Tucci, A., additional, Cabras, M. G., additional, Zilioli, V. R., additional, Rusconi, C., additional, Angrilli, F., additional, Arcaini, L., additional, Iwanicka, A. Dabrowska, additional, Ferreri, A.J.M., additional, Merli, F., additional, Zhao, W., additional, Hodgson, D., additional, Ionescu, C., additional, Fosså, A., additional, Cwynarski, K., additional, Mikhaeel, G., additional, Jerkeman, M., additional, Janikova, A., additional, Hüttmann, A., additional, Ciccone, G., additional, Metser, U., additional, Barrington, S., additional, Malkowski, B., additional, Versari, A., additional, Esposito, F., additional, Cozens, K., additional, Ielmini, N., additional, Ricardi, R., additional, Cavalli, F., additional, Johnson, P., additional, and Davies, A., additional

Published
2021
Full Text
View/download PDF

12. INTENSIFIED (INTRAVENOUS AND INTRATHECAL) CNS PROPHYLAXIS IN PRIMARY TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: 5‐YEAR RESULTS OF THE IELSG30 TRIAL

Author

Conconi, A., primary, Chiappella, A., additional, Orsucci, L., additional, Gaidano, G., additional, Ferreri, Andrés J.M., additional, Balzarotti, M., additional, Tucci, A., additional, Botto, B., additional, Moccia, A., additional, Vanazzi, A., additional, Merli, F., additional, Tani, M., additional, Esposito, F., additional, Bonomini, L., additional, Vitolo, U., additional, and Zucca, E., additional

Published
2021
Full Text
View/download PDF

13. DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN LATE‐OCTOGENARIAN (LO) PATIENTS: A SUBSTUDY OF THE “ELDERLY PROJECT” BY THE FONDAZIONE ITALIANA LINFOMI (FIL)

Author

Tucci, A., primary, Merli, F., additional, Fabbri, A., additional, Mancuso, S., additional, Sartori, R., additional, Storti, S., additional, Luminari, S., additional, Mammi, C., additional, Marcheselli, L., additional, Arcari, A., additional, Cavallo, F., additional, Zilioli, V. R., additional, Bottelli, C., additional, Re, A., additional, Gini, G., additional, Cox, M. C., additional, Puccini, B., additional, Pagani, C., additional, Balzarotti, M., additional, Spina, M., additional, and Rossi, G., additional

Published
2021
Full Text
View/download PDF

14. Risk Reduction of Chemical Residues in Soils and Crops - Impact Due to Wastewater Used for Irrigation (RESIDUE)

Author

Hennecke, D., Ortega Calvo, J. J., Drabkin, D., Schatten, R., Terytze, K., Maor, Y., Chefetz, N., Re, I., Balzarotti, M., and Weinfurtner, K.

Abstract

del Poster presentado en the SETAC Europe 31st Annual Meeting from 2–6 May 2021 in Seville, Spain., The current project is a cooperation of 5 partner from 4 European countries under the PRIMA research programme. It started in August 2020 and we are going to present the project concept and first project results. The goal of the projec is to enhance food quality/security by an evaluation of the risks associated with agricultural techniques, using sewage sludge for soil fertilization and treated wastewater for irrigation. Associated contaminants may reach the soils and plants, representing a risk to the consumer. In the project, we develop an improved treatment of waste materials prior to spreading based on biochar techniques. We study the fate and distribution of selected relevant contaminants from treatment of the waste materials until crop harvest. 14C-radiolabelled contaminants allow an advanced evaluation to extend the risk assessment for transformation products and bound residues. As an integral part of the project, soil qualities and sustainable use of waste materials in agriculture will be an important result of the study. To ensure practical relevance of the project, advancement will be pursued by the involvement of stakeholders (farmers¿ cooperatives, trade associations) to evaluate the applicability of the proposed technologies. Further, a user manual will be prepared that can serve as guidance on how to implement the research results in agricultural practise. As countries like Israel have no choice to use waste materials in agriculture, the project will support e.g. the Israel export agricultural business. In Spain and Italy basically the same applies: the high rate of treated sewage sludge and wastewater used in agriculture raises the same concerns. This demonstrates the project relevance, because it will provide new insights into the risk associated to this agricultural practice, as related to chemical pollution and food-safety issues. For countries like Germany, where water limitations might get more relevance in the future as a result of climatic change, the project will be of value for the safety and quality assessment of sewage sludge application in agriculture. Sewage sludge may find a broader application again if the risk for contamination can be reduced, because sewage sludge brings valuable organic matter and plant nutrients to soil.

Published
2021

15. Risk Reduction of Chemical Residues in Soils and Crops - Impact Due to Wastewater Used for Irrigation (RESIDUE)

Author

Hennecke, Dieter, Ortega Calvo, J. J., Drabkin, D., Schatten, R., Terytze, K., Maor, Y., Chefetz, N., Re, I., Balzarotti, M., Weinfurtner, K., Hennecke, Dieter, Ortega Calvo, J. J., Drabkin, D., Schatten, R., Terytze, K., Maor, Y., Chefetz, N., Re, I., Balzarotti, M., and Weinfurtner, K.

Abstract

The current project is a cooperation of 5 partner from 4 European countries under the PRIMA research programme. It started in August 2020 and we are going to present the project concept and first project results. The goal of the projec is to enhance food quality/security by an evaluation of the risks associated with agricultural techniques, using sewage sludge for soil fertilization and treated wastewater for irrigation. Associated contaminants may reach the soils and plants, representing a risk to the consumer. In the project, we develop an improved treatment of waste materials prior to spreading based on biochar techniques. We study the fate and distribution of selected relevant contaminants from treatment of the waste materials until crop harvest. 14C-radiolabelled contaminants allow an advanced evaluation to extend the risk assessment for transformation products and bound residues. As an integral part of the project, soil qualities and sustainable use of waste materials in agriculture will be an important result of the study. To ensure practical relevance of the project, advancement will be pursued by the involvement of stakeholders (farmers¿ cooperatives, trade associations) to evaluate the applicability of the proposed technologies. Further, a user manual will be prepared that can serve as guidance on how to implement the research results in agricultural practise. As countries like Israel have no choice to use waste materials in agriculture, the project will support e.g. the Israel export agricultural business. In Spain and Italy basically the same applies: the high rate of treated sewage sludge and wastewater used in agriculture raises the same concerns. This demonstrates the project relevance, because it will provide new insights into the risk associated to this agricultural practice, as related to chemical pollution and food-safety issues. For countries like Germany, where water limitations might get more relevance in the future as a result of climatic chan

Published
2021

23. COMPREHENSIVE ANALYSIS OF BASELINE OUTCOME BIOPREDICTORS IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: THE ANCILLARY BIOLOGICAL STUDIES OF FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 CLINICAL TRIAL

Author

Ferrero, S., Zaccaria, G. M., Barbero, D., Evangelista, A., Di Rocco, A., Re, A., Stefoni, V., Cavallo, F., Vitolo, U., Balzarotti, M., Rusconi, C., da Silva, Gomes M., Ghislieri, M., Omedè, P., Zamò, A., Ciccone, G., Gattei, V., Gaidano, G., Cortelazzo, S., and Ladetto, M.

Published
2019

29. Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group

Author

Zucca, E., Conconi, A., Mughal, T.I., Sarris, A.H., Seymour, J.F., Vitolo, U., Klasa, R., Ozsahin, M., Mead, G.M., Gianni, M.A., Cortelazzo, S., Ferreri, A.J.M., Ambrosetti, A., Martelli, M., Thiéblemont, C., Moreno, H. Gomez, Pinotti, G., Martinelli, G., Mozzana, R., Grisanti, S., Provencio, M., Balzarotti, M., Laveder, F., Oltean, G., Callea, V., Roy, P., Cavalli, F., and Gospodarowicz, M.K.

Published
2003

35. The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)

Author

Chauvie, S, Bergesio, F, Fioroni, F, Brambilla, M, Biggi, A, Versari, A, Guerra, L, Storto, G, Musto, P, Luminari, S, Cabras, M, Balzarotti, M, Rigacci, L, Martelli, M, Vitolo, U, Federico, M, Gallamini, A, Chauvie S., Bergesio F., Fioroni F., Brambilla M., Biggi A., Versari A., Guerra L., Storto G., Musto P., Luminari S., Cabras M. G., Balzarotti M., Rigacci L., Martelli M., Vitolo U., Federico M., Gallamini A., Chauvie, S, Bergesio, F, Fioroni, F, Brambilla, M, Biggi, A, Versari, A, Guerra, L, Storto, G, Musto, P, Luminari, S, Cabras, M, Balzarotti, M, Rigacci, L, Martelli, M, Vitolo, U, Federico, M, Gallamini, A, Chauvie S., Bergesio F., Fioroni F., Brambilla M., Biggi A., Versari A., Guerra L., Storto G., Musto P., Luminari S., Cabras M. G., Balzarotti M., Rigacci L., Martelli M., Vitolo U., Federico M., and Gallamini A.

Abstract

Purpose: The quantitative assessment of Positron Emission Tomography (PET) scans using standardized uptake value and derived parameters proved to be superior to traditional qualitative assessment in several retrospective or mono-centric prospective reports. Since different scanners give different quantitative readings, a program for clinical trial qualification (CTQ) is mandatory to guarantee a reliable and reproducible use of quantitative PET in prospective multi-centre clinical trials and in every-day clinical life. Methods: We set up, under the auspices of Italian Foundation on Lymphoma (FIL), a CTQ program consisting of the PET/CT scan acquisition and analysis of 18F and 68Ge NEMA/IEC image quality phantoms for the reduction of inter-scanner variability. Variability was estimated on background activity concentration (BAC) and sphere to background ratio (SBR). Results: The use of a 68Ge phantom allowed reducing the inter-scanner variability among different scanners from 74.0% to 20.5% in BAC and from 63.3% to 17.4% in SBR compared to using the 18F phantom. The CTQ criteria were fulfilled at first round in 100% and 28% of PET scanners with 68Ge and 18F respectively. Conclusions: The 68Ge phantom proved a reliable tool for PET scanner qualification, able to significantly reduce the potential sources of error while increasing the reproducibility of PET derived quantitative parameter measurement.

Published
2016

37. PET-DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL)

Author

Balzarotti, M., primary, Ricardi, U., additional, Spina, M., additional, Monagheddu, C., additional, Tucci, A., additional, Cavallo, F., additional, Zanni, M., additional, Arcari, A., additional, Rusconi, C., additional, Sartori, R., additional, Merli, F., additional, Re, F., additional, Vitolo, U., additional, Dessi, D., additional, Melis, L., additional, Gaidano, G., additional, Chiti, A., additional, Deidda, M., additional, Santoro, A., additional, Ciccone, G., additional, Chauvie, S., additional, and Cabras, M., additional

Published
2019
Full Text
View/download PDF

38. DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMI

Author

Mazza, R., primary, Spina, M., additional, Califano, C., additional, Gaudio, F., additional, Carella, M., additional, Consoli, U., additional, Palombi, F., additional, Musso, M., additional, Pulsoni, A., additional, Kovalchuk, S., additional, Bonfichi, M., additional, Ricci, F., additional, Fabbri, A., additional, Liberati, A., additional, Rodari, M., additional, Giordano, L., additional, Balzarotti, M., additional, Gallamini, A., additional, Ricardi, U., additional, Chauvie, S., additional, Merli, F., additional, Carlo-Stella, C., additional, and Santoro, A., additional

Published
2019
Full Text
View/download PDF

39. OUTCOMES IN FIRST RELAPSED-REFRACTORY YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE MANTLE-FIRST STUDY

Author

Visco, C., primary, Di Rocco, A., additional, Tisi, M.C., additional, Morello, L., additional, Evangelista, A., additional, Zilioli, V.R., additional, Rusconi, C., additional, Hohaus, S., additional, Sciarra, R., additional, Re, A., additional, Tecchio, C., additional, Chiappella, A., additional, Marin-Niebla, A., additional, McCulloch, R., additional, Gini, G., additional, Perrone, T., additional, Nassi, L., additional, Pennese, E., additional, Stefani, P.M., additional, Cox, M.C., additional, Bozzoli, V., additional, Fabbri, A., additional, Polli, V., additional, Ferrero, S., additional, De Celis, I.A., additional, Sica, A., additional, Arcaini, L., additional, Balzarotti, M., additional, Rule, S., additional, and Vitolo, U., additional

Published
2019
Full Text
View/download PDF

40. PS1248 COMPREHENSIVE ANALYSIS OF BASELINE OUTCOME BIOPREDICTORS IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: THE ANCILLARY BIOLOGICAL STUDIES OF FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 CLINICAL TRIAL

Author

Ferrero, S., primary, Zaccaria, G.M., additional, Barbero, D., additional, Evangelista, A., additional, Rocco, A. Di, additional, Re, A., additional, Stefoni, V., additional, Cavallo, F., additional, Vitolo, U., additional, Balzarotti, M., additional, Rusconi, C., additional, da Silva, M. Gomes, additional, Ghislieri, M., additional, Omedè, P., additional, Zamò, A., additional, Ciccone, G., additional, Gattei, V., additional, Gaidano, G., additional, Cortelazzo, S., additional, and Ladetto, M., additional

Published
2019
Full Text
View/download PDF

41. THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A PROSPECTIVE COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) OF 1353 ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

Author

Spina, M., primary, Merli, F., additional, Puccini, B., additional, Cavallo, F., additional, Cabras, M.G., additional, Fabbri, A., additional, Angrilli, F., additional, Zilioli, V.R., additional, Marino, D., additional, Balzarotti, M., additional, Ladetto, M., additional, Cox, M.C., additional, Petrucci, L., additional, Arcari, A., additional, Gini, G., additional, Chiappella, A., additional, Hohaus, S., additional, Musuraca, G., additional, Merli, M., additional, Sartori, R., additional, Nassi, L., additional, Tani, M., additional, Re, F., additional, Flenghi, L., additional, Molinari, A., additional, Kovalchuk, S., additional, Bottelli, C., additional, Ferrero, S., additional, Dessì, D., additional, Cencini, E., additional, Pennese, E., additional, Marcheselli, L., additional, Mammi, C., additional, Luminari, S., additional, and Tucci, A., additional

Published
2019
Full Text
View/download PDF

42. S1597 PET-DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL)

Author

Balzarotti, M., primary, Spina, M., additional, Monagheddu, C., additional, Chauvie, S., additional, Tucci, A., additional, Cavallo, F., additional, Zanni, M., additional, Arcari, A., additional, Rusconi, C., additional, Sartori, R., additional, Merli, F., additional, Re, F., additional, Vitolo, U., additional, Melis, L., additional, Navarria, P., additional, Gini, G., additional, Dessì, D., additional, Chiti, A., additional, Santoro, A., additional, Ciccone, G., additional, Ricardi, U., additional, and Cabras, M.G., additional

Published
2019
Full Text
View/download PDF

43. IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RECURRENCE OF MANTLE CELL LYMPHOMA

Author

Rusconi, C., primary, Tucker, D., additional, Bernard, S., additional, Muzi, C., additional, Crucitti, L., additional, Stefani, P., additional, Cox, M., additional, Gini, G., additional, Re, A., additional, Sciarra, R., additional, Liberati, A., additional, Morello, L., additional, Arcari, A., additional, Mannina, D., additional, Vitagliano, O., additional, Sartori, R., additional, Chiappella, A., additional, Balzarotti, M., additional, Vitolo, U., additional, Thieblemont, C., additional, Rule, S., additional, and Visco, C., additional

Published
2019
Full Text
View/download PDF

44. PS1237 DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVOURABLE HODGKIN LYMPHOMA (CHL): RESULTS OF A PHASE II, PROSPECTIVE, MULTI-CENTER STUDY BY FONDAZIONE ITALIANA LINFOMI

Author

Mazza, R., primary, Spina, M., additional, Califano, C., additional, Gaudio, F., additional, Carella, M., additional, Consoli, U., additional, Palombi, F., additional, Musso, M., additional, Pulsoni, A., additional, Kovalchuk, S., additional, Bonfichi, M., additional, Ricci, F., additional, Fabbri, A., additional, Liberati, A.M., additional, Rodari, M., additional, Giordano, L., additional, Balzarotti, M., additional, Gallamini, A., additional, Ricardi, U., additional, Chauvie, S., additional, Merli, F., additional, Carlo-Stella, C., additional, and Santoro, A., additional

Published
2019
Full Text
View/download PDF

46. THE PROGNOSTIC ROLE OF CELL OF ORIGIN PROFILE AND OVEREXPRESSION OF MYC ASSESSED BY IMMUNOHISTOCHEMISTRY IN YOUNG HIGH-RISK PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS OF FIRST LINE RANDOMIZED BIO-DLCL04 TRIAL OF FONDAZIONE ITALIANA LINFOMI

Author

ANNALISA CHIAPPELLA, Agostinelli, C., Martelli, M., Righi, S., Evangelista, A., Novero, D., Gotti, M., Carella, A. M., Stelitano, C., Tucci, A., Cabras, M. G., Balzarotti, M., Gaidano, G., Ladetto, M., Pileri, S. A., Vitolo, U., Chiappella, A, Agostinelli, C, Martelli, M, Righi, S, Evangelista, A, Novero, D, Gotti, M, Carella, AM, Stelitano, C, Tucci, A, Cabras, MG, Balzarotti, M, Gaidano, G, Ladetto, M, Pileri, SA, and Vitolo, U

Subjects
CELL OF ORIGIN, IMMUNOHISTOCHEMISTRY, DLBCL, MYC
Published
2015

48. Autologous stem cell transplantation (ASCT) or whole-brain radiotherapy (WBRT) as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with newly diagnosed primary cns lymphoma (PCNSL): results of the IELSG32 randomized Phase II Trial

Author

Ferreri, A. J. M., Cwynarski, K., Pulczynski, E., Fox, C. P., Schorb, E., La Rosee, P., Binder, M., Fabbri, A., Torri, V., Minacapelli, E., Falautano, M., Ilariucci, F., Ambrosetti, A., Roth, A., Hemmaway, C., Johnson, P., Linton, K. M., Pukrop, T., Gorlov, J. S., Balzarotti, M., Hess, G., Keller, U., Stilgenbauer, S., Panse, J., Tucci, A., Orsucci, L., Pisani, F., Levis, A., Krause, S., Schmoll, H. J., Hertenstein, B., Zaccaria, A., Guarini, A., Atta, J., Bassan, R., Cervetti, J., Elter, T., Enggaard, L., Haenel, M., Kneba, M., Liberati, M., Martelli, M., Martens, U., Morra, E., Pinto, A., Zaja, F., Ponzoni, M., Deckert, M., Politi, L. S., Finke, J., Reni, M., Cavalli, F., Zucca, E., Illerhaus, G., Ferreri, A. J. M., Cwynarski, K., Pulczynski, E., Fox, C. P., Schorb, E., La Rosee, P., Binder, M., Fabbri, A., Torri, V., Minacapelli, E., Falautano, M., Ilariucci, F., Ambrosetti, A., Roth, A., Hemmaway, C., Johnson, P., Linton, K. M., Pukrop, T., Gorlov, J. S., Balzarotti, M., Hess, G., Keller, U., Stilgenbauer, S., Panse, J., Tucci, A., Orsucci, L., Pisani, F., Levis, A., Krause, S., Schmoll, H. J., Hertenstein, B., Zaccaria, A., Guarini, A., Atta, J., Bassan, R., Cervetti, J., Elter, T., Enggaard, L., Haenel, M., Kneba, M., Liberati, M., Martelli, M., Martens, U., Morra, E., Pinto, A., Zaja, F., Ponzoni, M., Deckert, M., Politi, L. S., Finke, J., Reni, M., Cavalli, F., Zucca, E., and Illerhaus, G.

Published
2017

49. BIODLCL04: THE PROGNOSTIC ROLE OF CELL OF ORIGIN PROFILE, MYC, BCL2, AND TP53 IN UNTREATED POOR-RISK DIFFUSE LARGE B-CELL LYMPHOMA

Author

Chiappella, A., primary, Agostinelli, C., additional, Martelli, M., additional, Evangelista, A., additional, Fabbri, M., additional, Melle, F., additional, Motta, G., additional, Righi, S., additional, Novero, D., additional, Balzarotti, M., additional, Cabras, M.G., additional, Carella, A.M., additional, Gotti, M., additional, Pavone, V., additional, Tucci, A., additional, Ladetto, M., additional, Gaidano, G., additional, Vitolo, U., additional, and Pileri, S.A., additional

Published
2017
Full Text
View/download PDF

50. LONG TERM RESULTS OF THE FOLL05 RANDOMIZED STUDY COMPARING R-CVP WITH R-CHOP AND R-FM AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA. A FIL STUDY

Author

Luminari, S., primary, Tarantino, V., additional, Anastasia, A., additional, Boccomini, C., additional, Chiarenza, A., additional, Rigacci, L., additional, Angelucci, E., additional, Ferrari, A., additional, Pulsoni, A., additional, Rattotti, S., additional, Angrilli, F., additional, Gaidano, G., additional, Stelitano, C., additional, Bertoldero, G., additional, Cascavilla, N., additional, Salvi, F., additional, Ferreri, A.J., additional, Vallisa, D., additional, Balzarotti, M., additional, Cox, M.C., additional, Freilone, R., additional, Marcheselli, L., additional, Dondi, A., additional, Manni, M., additional, and Federico, M., additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results